Login
Home
Charts
Search
Watchlist
Products

Sun Pharma Advanced Research Company Ltd

SPARC·NSE
₹205.65+3.88%Wed, 23 Sept '26 15:58
Industry:Pharma - Others
Indices:

Sun Pharma Advanced Research Company Ltd

SPARC
NSE
₹205.65
+3.88%
|Wed, 23 Sept '26 15:58
SOICxStockScans Reports
Industry
Pharma - Others
Indices
View
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹6,674Cr
Close
Close Price
₹205.66
Industry
Industry
Pharma - Others
PE
Price To Earnings
4.21
PS
Price To Sales
3.50
Revenue
Revenue
₹1,909Cr
Rev Gr TTM
Revenue Growth TTM
2,855.80%
PAT Gr TTM
PAT Growth TTM
630.79%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
2114171713152710881,85340
Growth YoY
Revenue Growth YoY%
-65.3-29.8-39.37.664.2-42.6-38.9-43.36,715.8314.1
Expenses
ExpensesCr
11311612211011689806274658074
Operating Profit
Operating ProfitCr
-91-103-106-93-103-74-53-52-66-571,773-34
OPM
OPM%
-431.9-740.4-639.1-555.4-800.2-494.2-195.6-540.3-836.1-670.395.7-85.2
Other Income
Other IncomeCr
864200090-12224
Interest Expense
Interest ExpenseCr
0011135689128
Depreciation
DepreciationCr
333333333322
PBT
PBTCr
-86-100-105-96-107-79-61-52-76-801,761-21
Tax
TaxCr
000000-100000
PAT
PATCr
-86-100-106-96-107-80-60-52-76-801,761-21
Growth YoY
PAT Growth YoY%
-29.0-0.6-24.220.243.545.929.3-1.13,046.959.9
NPM
NPM%
-408.0-719.0-638.8-570.5-834.6-533.3-219.8-538.1-965.0-951.795.0-52.0
EPS
EPS₹
-2.7-3.1-3.3-3.0-3.3-2.5-1.8-1.6-2.3-2.554.3-0.6
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
2114171713152710881,85340
Growth YoY
Revenue Growth YoY%
-65.3-29.8-39.37.664.2-42.6-38.9-43.36,715.8314.1
Expenses
ExpensesCr
11311612211011689806274658074
Operating Profit
Operating ProfitCr
-91-103-106-93-103-74-53-52-66-571,773-34
OPM
OPM%
-431.9-740.4-639.1-555.4-800.2-494.2-195.6-540.3-836.1-670.395.7-85.2
Other Income
Other IncomeCr
864200090-12224
Interest Expense
Interest ExpenseCr
0011135689128
Depreciation
DepreciationCr
333333333322
PBT
PBTCr
-86-100-105-96-107-79-61-52-76-801,761-21
Tax
TaxCr
000000-100000
PAT
PATCr
-86-100-106-96-107-80-60-52-76-801,761-21
Growth YoY
PAT Growth YoY%
-29.0-0.6-24.220.243.545.929.3-1.13,046.959.9
NPM
NPM%
-408.0-719.0-638.8-570.5-834.6-533.3-219.8-538.1-965.0-951.795.0-52.0
EPS
EPS₹
-2.7-3.1-3.3-3.0-3.3-2.5-1.8-1.6-2.3-2.554.3-0.6

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
23976721,8791,909
Growth
Revenue Growth%
-68.4-5.02,518.52,855.8
Expenses
ExpensesCr
453478395280293
Operating Profit
Operating ProfitCr
-214-402-3231,5991,617
OPM
OPM%
-89.7-532.3-450.385.184.7
Other Income
Other IncomeCr
11292-113
Interest Expense
Interest ExpenseCr
8293436
Depreciation
DepreciationCr
1213121010
PBT
PBTCr
-223-387-3431,5531,584
Tax
TaxCr
00000
PAT
PATCr
-223-387-3431,5531,584
Growth
PAT Growth%
-74.011.6553.5630.8
NPM
NPM%
-93.2-512.6-477.382.783.0
EPS
EPS₹
-7.8-11.9-10.647.948.8
Financial YearMar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
23976721,8791,909
Growth
Revenue Growth%
-68.4-5.02,518.52,855.8
Expenses
ExpensesCr
453478395280293
Operating Profit
Operating ProfitCr
-214-402-3231,5991,617
OPM
OPM%
-89.7-532.3-450.385.184.7
Other Income
Other IncomeCr
11292-113
Interest Expense
Interest ExpenseCr
8293436
Depreciation
DepreciationCr
1213121010
PBT
PBTCr
-223-387-3431,5531,584
Tax
TaxCr
00000
PAT
PATCr
-223-387-3431,5531,584
Growth
PAT Growth%
-74.011.6553.5630.8
NPM
NPM%
-93.2-512.6-477.382.783.0
EPS
EPS₹
-7.8-11.9-10.647.948.8

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
32323232
Reserves
ReservesCr
48093-2491,306
Current Liabilities
Current LiabilitiesCr
179265374754
Non Current Liabilities
Non Current LiabilitiesCr
13812417878
Total Liabilities
Total LiabilitiesCr
8305153362,171
Current Assets
Current AssetsCr
455269261,862
Non Current Assets
Non Current AssetsCr
375246309308
Total Assets
Total AssetsCr
8305153362,171
Financial YearMar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
32323232
Reserves
ReservesCr
48093-2491,306
Current Liabilities
Current LiabilitiesCr
179265374754
Non Current Liabilities
Non Current LiabilitiesCr
13812417878
Total Liabilities
Total LiabilitiesCr
8305153362,171
Current Assets
Current AssetsCr
455269261,862
Non Current Assets
Non Current AssetsCr
375246309308
Total Assets
Total AssetsCr
8305153362,171

Cash Flow

Consolidated
Standalone
Financial YearMar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-69-429-360-239
Investing Cash Flow
Investing Cash FlowCr
-548392158-24
Financing Cash Flow
Financing Cash FlowCr
61742199261
Net Cash Flow
Net Cash FlowCr
-15-3-1
Free Cash Flow
Free Cash FlowCr
-84-455-370-262
CFO To PAT
CFO To PAT%
31.1110.8105.2-15.4
CFO To EBITDA
CFO To EBITDA%
32.3106.7111.5-14.9
Financial YearMar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-69-429-360-239
Investing Cash Flow
Investing Cash FlowCr
-548392158-24
Financing Cash Flow
Financing Cash FlowCr
61742199261
Net Cash Flow
Net Cash FlowCr
-15-3-1
Free Cash Flow
Free Cash FlowCr
-84-455-370-262
CFO To PAT
CFO To PAT%
31.1110.8105.2-15.4
CFO To EBITDA
CFO To EBITDA%
32.3106.7111.5-14.9

Ratios

Consolidated
Standalone
Financial YearMar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
5,82412,0064,8033,7196,674
Price To Earnings
Price To Earnings
2.44.2
Price To Sales
Price To Sales
24.4158.966.92.03.5
Price To Book
Price To Book
11.495.3-22.22.85.0
EV To EBITDA
EV To EBITDA
-26.8-29.6-15.72.74.3
Profitability Ratios
Profitability Ratios
GPM
GPM%
84.136.740.297.897.8
OPM
OPM%
-89.7-532.3-450.385.184.7
NPM
NPM%
-93.2-512.6-477.382.783.0
ROCE
ROCE%
-40.7-206.1-642.083.683.6
ROE
ROE%
-43.4-307.9157.9116.0116.0
ROA
ROA%
-26.8-75.2-102.171.571.5
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
5,82412,0064,8033,7196,674
Price To Earnings
Price To Earnings
2.44.2
Price To Sales
Price To Sales
24.4158.966.92.03.5
Price To Book
Price To Book
11.495.3-22.22.85.0
EV To EBITDA
EV To EBITDA
-26.8-29.6-15.72.74.3
Profitability Ratios
Profitability Ratios
GPM
GPM%
84.136.740.297.897.8
OPM
OPM%
-89.7-532.3-450.385.184.7
NPM
NPM%
-93.2-512.6-477.382.783.0
ROCE
ROCE%
-40.7-206.1-642.083.683.6
ROE
ROE%
-43.4-307.9157.9116.0116.0
ROA
ROA%
-26.8-75.2-102.171.571.5
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios

Documents — Sun Pharma Advanced Research Company Ltd

  • Q4 FY2024 Earnings Call Transcript (Mar 2024, PDF): https://www.stockscans.in/document/tddc3a8luyc7p79fu64tulsx.pdf
  • Q3 FY2024 Earnings Call Transcript (Dec 2023, PDF): https://www.stockscans.in/document/8ff6zwnz4aph2fii8dhil3vu.pdf
  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/44etzeepym08tcdnujytregj.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/t3ttk8cwx4z5s63k8srzhxpu.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/77udh9yoae4l0ln4dj49brhf.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/sze67qrm22idbfny5uicakcn.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/e46f7c9ygsaovrnp8e4bsvtg.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/i4ltlnqhe2sqc3d784ipl0df.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/604wjse6eat6u482w68h14si.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/0jqblrutzxm4kuu6sw4qv8vq.pdf
  • Q3 FY2026 Investor Presentation (Dec 2025, PDF): https://www.stockscans.in/document/juj51bl75t6nz2f1x1mks84b.pdf
  • Q2 FY2025 Investor Presentation (Sep 2024, PDF): https://www.stockscans.in/document/f1q94nqfi5juzao7p26543n2.pdf
  • Q3 FY2024 Investor Presentation (Dec 2023, PDF): https://www.stockscans.in/document/1l3h1dgem72eq3a4dcgqj7oz.pdf
  • Q2 FY2024 Investor Presentation (Sep 2023, PDF): https://www.stockscans.in/document/b93hpvznlegzbptgl0tak3ct.pdf
  • Q2 FY2023 Investor Presentation (Sep 2022, PDF): https://www.stockscans.in/document/hm83wxxln1j64ett0e40eg60.pdf
  • Q2 FY2022 Investor Presentation (Sep 2021, PDF): https://www.stockscans.in/document/r9ocimcsg6zico08dg0y0rdk.pdf
  • Q1 FY2021 Investor Presentation (Jun 2020, PDF): https://www.stockscans.in/document/k6c5n9vim3nmupuzko3n8ek6.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/fxedi60sqsk0knmk3ysahgtq.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/wkzfz6k4va4drri2vozflz16.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/a2vo7dn8yqn7pl52se3aloku.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/b95wdmdrlftkd4hy0r6d1fui.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/1bihfvtei654rerahxa7a6wh.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/f4mrt0fqtlhoakp6kenta530.pdf
  • FY2020 Annual Report (PDF): https://www.stockscans.in/document/4c23nt9jcr04l1c84fgtvb16.pdf

Concall Transcript Summaries — Sun Pharma Advanced Research Company Ltd

  • Q4 FY2024 Concall Transcript Summary (Mar 2024): https://www.stockscans.in/company/NSE%3ASPARC/transcript-notes/202403/tddc3a8luyc7p79fu64tulsx.pdf
  • Q3 FY2024 Concall Transcript Summary (Dec 2023): https://www.stockscans.in/company/NSE%3ASPARC/transcript-notes/202312/8ff6zwnz4aph2fii8dhil3vu.pdf

Simplify stock analysis with powerful tools and clear insights for confident, data-driven decisions.

support@stockscans.in
© StockScans by SOIC Technologies Pvt Ltd
349 A, Lodhi Road, Punjabi Bazar, New DelhiData provided by CMOTS Internet Technologies